ArticleBlood advances2022

Loss of METTL3 attenuates blastic plasmacytoid dendritic cell neoplasm response to PRMT5 inhibition via IFN signaling.

Malini Rethnam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.